Silence Therapeutics (SLN) Net Margin (2020 - 2025)
Historic Net Margin for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to 13181.13%.
- Silence Therapeutics' Net Margin fell 105653600.0% to 13181.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 249.86%, marking a year-over-year increase of 1580600.0%. This contributed to the annual value of 104.74% for FY2024, which is 649700.0% up from last year.
- Per Silence Therapeutics' latest filing, its Net Margin stood at 13181.13% for Q3 2025, which was down 105653600.0% from 12211.61% recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Net Margin ranged from a high of 48.61% in Q4 2024 and a low of 313931.3% during Q1 2021
- For the 5-year period, Silence Therapeutics' Net Margin averaged around 19372.61%, with its median value being 381.02% (2023).
- As far as peak fluctuations go, Silence Therapeutics' Net Margin skyrocketed by 2000000000bps in 2021, and later crashed by -200643600bps in 2025.
- Silence Therapeutics' Net Margin (Quarter) stood at 0.0% in 2021, then plummeted by -253221284bps to 315.84% in 2022, then tumbled by -126bps to 713.01% in 2023, then skyrocketed by 107bps to 48.61% in 2024, then crashed by -27213bps to 13181.13% in 2025.
- Its Net Margin was 13181.13% in Q3 2025, compared to 12211.61% in Q2 2025 and 20091.55% in Q1 2025.